375 related articles for article (PubMed ID: 31407167)
21. Long-term outcomes after surgical dissection of inguinal lymph node metastasis from rectal or anal canal adenocarcinoma.
Tanabe T; Shida D; Komukai S; Nakamura Y; Tsukamoto S; Kanemitsu Y
BMC Cancer; 2019 Jul; 19(1):733. PubMed ID: 31340778
[TBL] [Abstract][Full Text] [Related]
22. Lateral Pelvic Lymph Node Metastases in Rectal Cancer: A Systematic Review.
Atef Y; Koedam TW; van Oostendorp SE; Bonjer HJ; Wijsmuller AR; Tuynman JB
World J Surg; 2019 Dec; 43(12):3198-3206. PubMed ID: 31468119
[TBL] [Abstract][Full Text] [Related]
23. Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.
Sekido Y; Nishimura J; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Haraguchi N; Hata T; Matsuda C; Mizushima T; Murata K; Hasegawa J; Mori M; Doki Y
Surg Today; 2020 Mar; 50(3):292-297. PubMed ID: 31595366
[TBL] [Abstract][Full Text] [Related]
24. [Lateral pelvic lymph node metastasis is an important prognostic factor for low rectal cancer].
Pan YS; Wan YL; Liu YC; Wang X; Wu T
Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):984-7. PubMed ID: 19957807
[TBL] [Abstract][Full Text] [Related]
25. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
26. Laparoscopic lateral pelvic lymph node dissection is achievable and offers advantages as a minimally invasive surgery over the open approach.
Nagayoshi K; Ueki T; Manabe T; Moriyama T; Yanai K; Oda Y; Tanaka M
Surg Endosc; 2016 May; 30(5):1938-47. PubMed ID: 26275538
[TBL] [Abstract][Full Text] [Related]
27. Selection of Lymph Node-Positive Cases Based on Perirectal and Lateral Pelvic Lymph Nodes Using Magnetic Resonance Imaging: Study of the Japanese Society for Cancer of the Colon and Rectum.
Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Kameoka S; Sugihara K
Ann Surg Oncol; 2016 Apr; 23(4):1187-94. PubMed ID: 26671038
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and safety of laparoscopic lateral pelvic lymph node dissection for locally recurrent rectal cancer and risk factors for re-recurrence.
Ichihara M; Ikeda M; Uemura M; Miyake M; Miyazaki M; Kato T; Sekimoto M
Asian J Endosc Surg; 2020 Oct; 13(4):489-497. PubMed ID: 31854108
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of metastatic tumor deposit foci in rectal cancer in the lateral pelvic lymph node area.
Yamai D; Shimada Y; Nakano M; Ozeki H; Matsumoto A; Abe K; Tajima Y; Nakano M; Ichikawa H; Sakata J; Nagai T; Ling Y; Okuda S; Watanabe G; Nogami H; Maruyama S; Takii Y; Wakai T
Int J Clin Oncol; 2023 Oct; 28(10):1388-1397. PubMed ID: 37481501
[TBL] [Abstract][Full Text] [Related]
31. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).
Komori K; Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Shiomi A; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Kinugasa Y; Takii Y; Akasu T; Moriya Y;
Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of lateral pelvic lymph node metastasis of T1 lower rectal cancer using diffusion-weighted magnetic resonance imaging: A case report with lateral pelvic lymph node dissection of lower rectal cancer.
Ogawa S; Itabashi M; Hirosawa T; Hashimoto T; Bamba Y; Okamoto T
Mol Clin Oncol; 2016 May; 4(5):817-820. PubMed ID: 27123286
[TBL] [Abstract][Full Text] [Related]
33. The Prognostic Significance of Isolated Tumor Cells Detected Within Lateral Lymph Nodes in Rectal Cancer Patients After Laparoscopic Lateral Lymph Node Dissection.
Yang X; Hu T; Gu C; Yang S; Jiang D; Deng X; Wang Z; Zhou Z
J Laparoendosc Adv Surg Tech A; 2019 Nov; 29(11):1462-1468. PubMed ID: 31539301
[No Abstract] [Full Text] [Related]
34. Indication and benefit of pelvic sidewall dissection for rectal cancer.
Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T
Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749
[TBL] [Abstract][Full Text] [Related]
35. Identification of patient subgroups with low risk of postoperative local recurrence for whom total mesorectal excision surgery alone is sufficient: a multicenter retrospective analysis.
Yamamoto T; Kawada K; Matsusue R; Kato S; Itatani Y; Hida K; Machimoto T; Yamaguchi T; Obama K
Int J Colorectal Dis; 2022 Oct; 37(10):2207-2218. PubMed ID: 36156129
[TBL] [Abstract][Full Text] [Related]
36. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for lateral pelvic lymph node metastasis in patients with lower rectal cancer: a systematic review and meta-analysis.
Zeng DX; Yang Z; Tan L; Ran MN; Liu ZL; Xiao JW
Front Oncol; 2023; 13():1219608. PubMed ID: 37746256
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients.
Kim TG; Park W; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Chun HK
Int J Colorectal Dis; 2014 Feb; 29(2):193-200. PubMed ID: 24322736
[TBL] [Abstract][Full Text] [Related]
39. The effect of pericolic lymph nodes metastasis beyond 10 cm proximal to the tumor on patients with rectal cancer.
Yang X; Zheng E; Ye L; Gu C; Hu T; Jiang D; He D; Wu B; Wu Q; Yang T; Wei M; Meng W; Deng X; Wang Z; Zhou Z
BMC Cancer; 2020 Jun; 20(1):573. PubMed ID: 32560635
[TBL] [Abstract][Full Text] [Related]
40. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
